Bui, LT; Winters, NI; Chung, MI; Joseph, C; Gutierrez, AJ; Habermann, AC; Adams, TS; ... Zaragosi, LE; + view all Bui, LT; Winters, NI; Chung, MI; Joseph, C; Gutierrez, AJ; Habermann, AC; Adams, TS; Schupp, JC; Poli, S; Peter, LM; Taylor, CJ; Blackburn, JB; Richmond, BW; Nicholson, AG; Rassl, D; Wallace, WA; Rosas, IO; Jenkins, RG; Kaminski, N; Kropski, JA; Banovich, NE; Misharin, AV; Tsankov, AM; Spira, A; Barbry, P; Brazma, A; Samakovlis, C; Shepherd, DP; Rawlins, EL; Theis, FJ; Griffonnet, J; Lee, H; Schiller, HB; Hofman, P; Powell, JE; Schultze, JL; Whitsett, J; Choi, J; Lundeberg, J; Banovich, NE; Ordovas-Montanes, J; Rajagopal, J; Ordovas-Montanes, J; Krasnow, MA; Saeb‐Parsy, K; Zhang, K; Lafyatis, R; Leroy, S; Haniffa, M; Nawijn, MC; Nikolić, MZ; van den Berge, M; Kuhnemund, M; Marquette, CH; Von Papen, M; Eickelberg, O; Rosenblatt-Rosen, O; Reyfman, PA; Pe’er, D; Horvath, P; Tata, PR; Regev, A; Rojas, M; Seibold, MA; Shalek, AK; Spence, JR; Teichmann, SA; Quake, S; Teichmann, SA; Biancalani, T; Desai, T; Sun, X; Zaragosi, LE; - view fewer (2021) Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity. Nature Communications , 12 , Article 4314. 10.1038/s41467-021-24467-0.